-
Top PBMs by 2023 market share
Three pharmacy benefit managers accounted for nearly 80% of all prescription claims handled in 2023, according to an April 9 report from the Drug Channels Institute. -
How pharmacy miscommunication can result in patient death: Case study
A jury awarded $42.4 million to the estate of a patient who died after staff failed to get the patient's baclofen prescription filled in a timely manner, a case study posted on the American Pharmacy Association website said. -
25 drugs at Mark Cuban's online pharmacy with biggest cost reductions
Two years after launching, Mark Cuban Cost Plus Drugs now sells hundreds of generics and about 20 branded medications for a discounted rate. It also partners with hospitals, independent pharmacies and pharmacy benefit managers. -
Kaiser pharmacists secure mid-contract wage increases
UFCW 3000, a union representing about 50,000 workers at health systems, retail stores and other businesses in three states, said it secured wage increases for some Kaiser Permanente employees. -
New York drugmaker files for bankruptcy
Acorda Therapeutics filed for Chapter 11 bankruptcy April 1. -
Pharmacist pay by state
The average pharmacist's salary in the U.S. is $134,790, and 15 states and Washington, D.C., are above the average, according to the most recent data from the Bureau of Labor Statistics. -
HHS 'misses the mark' in drug shortage proposal, ASHP says
The American Society of Health-System Pharmacists partly welcomed HHS' 18-page policy recommendations for drug shortage strategies, but the organization said it "proposes concerning penalties." -
Amylyx to swipe ALS from market after study failure
Amylyx Pharmaceuticals is withdrawing its FDA-approved therapy for amyotrophic lateral sclerosis, Relyvrio, from the market after a phase 3 study failure, the company said April 4. -
CVS Caremark leader jabs Cost Plus Drugs; Mark Cuban responds
David Joyner, executive vice president of CVS Health and president of CVS Caremark, called out Mark Cuban's drug company in a paid op-ed Fortune published April 3. -
5 top-paying industries for pharmacists
On average, general hospitals pay pharmacists more than retailers, but both industries are not among the five highest paying for the profession, according to data from the Bureau of Labor Statistics. -
FDA approves antibiotic for 3 uses
On April 3, the FDA approved Zevtera, an antibiotic with three different uses. -
CVS expands financial assistance for pharmacy students
CVS Health on April 3 unveiled a new tuition assistance program for pharmacy interns and a scholarship program for students in pharmacy school. -
A 'crystal ball prediction' for more 340B protections: ASHP expert
More than 25 states have enacted laws designed to protect against pharmacy benefit managers' discriminatory practices in the 340B program, the American Society of Health-System Pharmacists said April 2. -
HHS pitches rewards for hospitals with drug shortage solutions
Every year, U.S. hospitals spend at least $600 million to mitigate drug shortages, according to HHS. On April 2, the department proposed financial incentives for hospitals with resilient drug supplies. -
3 drugmakers announce recalls
In the past week, three pharmaceutical companies have recalled medications because of patient safety concerns. -
Amazon Pharmacy expands same-day delivery
Amazon Pharmacy is now offering same-day prescription medicine deliveries for customers in New York City and Los Angeles, with plans to expand to more than a dozen cities by the end of the year. -
10 drugs now in shortage
Since March 20, 10 more drugs are either in short supply or discontinued — and the healthcare supply chain industry is watching whether the collapse of a Baltimore bridge might cause disruptions. -
20 pharmacist- and dermatologist-recommended health products
On March 28, U.S. News & World Report released its latest over-the-counter medicine and health products ranking. -
Minnesota system adopts ScripTalk
Essentia Health, a 14-hospital system based in Duluth, Minn., launched a free tool March 26 to verbalize prescription labels. -
Zepbound in shortage
Patients, pharmacists and physicians are reporting a strained supply of Zepbound, Eli Lilly's new weight loss drug, as the drugmaker and the FDA say the medication is available, according to Bloomberg.
Page 4 of 50